![“Revving Up for Success: Carsgen’s Thank-U-Plus Trial Hits Milestone with First Enrolled Subject Achieving SCR at Week 4!”](https://marketsgonewild.com/wp-content/uploads/2025/02/Revving-Up-for-Success-Carsgens-Thank-U-Plus-Trial-Hits-Milestone-with-First-Enrolled-Subject-Achieving-SCR-at-Week-4-600x360.jpg)
“Revving Up for Success: Carsgen’s Thank-U-Plus Trial Hits Milestone with First Enrolled Subject Achieving SCR at Week 4!”
Welcome to the world of innovative CAR T-cell therapies! Exciting news from CARsgen Therapeutics Holdings Limited SHANGHAI, Feb. 9, 2025 CARsgen Therapeutics Holdings Limited, a company known for its groundbreaking CAR T-cell therapies, has just made a major breakthrough. The first patient treated with their allogeneic BCMA CAR-T therapy developed on the THANK-u Plus™ platform…